Cargando…

Cardiotoxicity of Selected Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Renal Cell Carcinoma

Renal cell carcinoma (RCC) is one of the most frequent malignant neoplasms of the kidney. The therapeutic options available for the treatment of advanced or metastatic RCC include vascular endothelial growth factor receptor (VEGFR)-targeted molecules, for example, tyrosine kinase inhibitors (TKI). V...

Descripción completa

Detalles Bibliográficos
Autores principales:	Franczyk, Beata, Rysz, Jacek, Ławiński, Janusz, Ciałkowska-Rysz, Aleksandra, Gluba-Brzózka, Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9855533/ https://www.ncbi.nlm.nih.gov/pubmed/36672689 http://dx.doi.org/10.3390/biomedicines11010181

Ejemplares similares

The Impact of Aerobic Exercise on HDL Quantity and Quality: A Narrative Review
por: Franczyk, Beata, et al.
Publicado: (2023)

The Impact of CKD on Uremic Toxins and Gut Microbiota
por: Rysz, Jacek, et al.
Publicado: (2021)

Renal Cell Cancer and Obesity
por: Gluba-Brzózka, Anna, et al.
Publicado: (2022)

Characteristics of Clear Cell Papillary Renal Cell Carcinoma (ccpRCC)
por: Rysz, Jacek, et al.
Publicado: (2021)

Diabetes and Cardiovascular Risk in Renal Transplant Patients
por: Rysz, Jacek, et al.
Publicado: (2021)

The Effect of Diet on the Survival of Patients with Chronic Kidney Disease
por: Rysz, Jacek, et al.
Publicado: (2017)

The Role of Metabolic Factors in Renal Cancers
por: Rysz, Jacek, et al.
Publicado: (2020)

The Role of Long Noncoding RNA (lncRNAs) Biomarkers in Renal Cell Carcinoma
por: Rysz, Jacek, et al.
Publicado: (2022)

Oxidative Stress in ESRD Patients on Dialysis and the Risk of Cardiovascular Diseases
por: Rysz, Jacek, et al.
Publicado: (2020)

Is a High HDL-Cholesterol Level Always Beneficial?
por: Franczyk, Beata, et al.
Publicado: (2021)

Metabolomic Profile in Venous Thromboembolism (VTE)
por: Franczyk, Beata, et al.
Publicado: (2021)

Emerging Anti-Atherosclerotic Therapies
por: Gluba-Brzózka, Anna, et al.
Publicado: (2021)

Novel Biomarkers in the Diagnosis of Chronic Kidney Disease and the Prediction of Its Outcome
por: Rysz, Jacek, et al.
Publicado: (2017)

Impact of Vitamin D on the Cardiovascular System in Advanced Chronic Kidney Disease (CKD) and Dialysis Patients
por: Gluba-Brzózka, Anna, et al.
Publicado: (2018)

The Role of miRNA in Renal Fibrosis Leading to Chronic Kidney Disease
por: Gluba-Sagr, Anna, et al.
Publicado: (2023)

Are Nutraceuticals Beneficial in Chronic Kidney Disease?
por: Rysz, Jacek, et al.
Publicado: (2021)

The role and function of HDL in patients with diabetes mellitus and the related cardiovascular risk
por: Femlak, Marek, et al.
Publicado: (2017)

miRNA biomarkers in renal disease
por: Franczyk, Beata, et al.
Publicado: (2021)

Vegetarian Diet in Chronic Kidney Disease—A Friend or Foe
por: Gluba-Brzózka, Anna, et al.
Publicado: (2017)

Cholesterol Disturbances and the Role of Proper Nutrition in CKD Patients
por: Gluba-Brzozka, Anna, et al.
Publicado: (2019)

Pharmacogenetics of Drugs Used in the Treatment of Cancers
por: Franczyk, Beata, et al.
Publicado: (2022)

Pharmacogenomics of Hypertension Treatment
por: Rysz, Jacek, et al.
Publicado: (2020)

The Role and Function of HDL in Patients with Chronic Kidney Disease and the Risk of Cardiovascular Disease
por: Rysz, Jacek, et al.
Publicado: (2020)

Ageing, Age-Related Cardiovascular Risk and the Beneficial Role of Natural Components Intake
por: Rysz, Jacek, et al.
Publicado: (2021)

Are Alterations in DNA Methylation Related to CKD Development?
por: Rysz, Jacek, et al.
Publicado: (2022)

The Role of Inflammation and Oxidative Stress in Rheumatic Heart Disease
por: Franczyk, Beata, et al.
Publicado: (2022)

Personalized Medicine: New Perspectives for the Diagnosis and the Treatment of Renal Diseases
por: Gluba-Brzózka, Anna, et al.
Publicado: (2017)

The Influence of Inflammation on Anemia in CKD Patients
por: Gluba-Brzózka, Anna, et al.
Publicado: (2020)

Oxidative Stress-Related Susceptibility to Aneurysm in Marfan’s Syndrome
por: Rysz, Jacek, et al.
Publicado: (2021)

The Influence of Dietary Interventions on Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD)
por: Rysz, Jacek, et al.
Publicado: (2021)

High-Sensitivity C-Reactive Protein Relationship with Metabolic Disorders and Cardiovascular Diseases Risk Factors
por: Koziarska-Rościszewska, Małgorzata, et al.
Publicado: (2021)

Will the Use of Pharmacogenetics Improve Treatment Efficiency in COVID-19?
por: Franczyk, Beata, et al.
Publicado: (2022)

Pathomechanisms of Immunological Disturbances in β-Thalassemia
por: Gluba-Brzózka, Anna, et al.
Publicado: (2021)

Molecular mechanisms of statin intolerance
por: Gluba-Brzozka, Anna, et al.
Publicado: (2016)

Markers of increased cardiovascular risk in patients with chronic kidney disease
por: Gluba-Brzózka, Anna, et al.
Publicado: (2014)

Markers of increased atherosclerotic risk in patients with chronic kidney disease: a preliminary study
por: Gluba-Brzózka, Anna, et al.
Publicado: (2016)

Serum NGAL, KIM-1, IL-18, L-FABP: new biomarkers in the diagnostics of acute kidney injury (AKI) following invasive cardiology procedures
por: Zdziechowska, Magdalena, et al.
Publicado: (2020)

Treatment of non-ST-elevation myocardial infarction and ST-elevation myocardial infarction in patients with chronic kidney disease
por: Franczyk-Skóra, Beata, et al.
Publicado: (2013)

Erratum to: Markers of increased atherosclerotic risk in patients with chronic kidney disease: a preliminary study
por: Gluba-Brzózka, Anna, et al.
Publicado: (2016)

Heart function disturbances in chronic kidney disease – echocardiographic indices
por: Franczyk-Skóra, Beata, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_jvgl1ou5mec59f8otvloqhu6tn